Zion Pharma

PharmaceuticalsSeries BShanghai, Chinazionpharma.com

Latest round

Series B

Last raised

Jul 2021

Total raised

$73M

Investors

6

About Zion Pharma

Based in Shanghai, China and established in 2018, Zion Pharma Limited is a bio-pharmaceutical company that focuses on the development of small molecule tumor drugs. Dr. Ziqiang Cheng, the company's co-founder and CEO, served as Director of Drug Metabolic Pharmacokinetics (DMPK) of AstraZeneca and GlaxoSmithKline The company engages in the development of small molecule tumor drugs. Its main product is ZN-A-1041. ZN-A-1041 is a best-in-class small molecule tyrosine kinase receptor inhibitor targeting HER2. It is used in the treatment of HER2 and advanced breast cancer brain metastases. The company also created a new drug discovery platform.

Who invested in Zion Pharma

6 investors across 4 rounds

See all investors in Zion Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 28, 2021

    Amount

    $40M

    Investors

    Locked

  2. Series A

    Jul 1, 2020

    Amount

    $20M

    Investors

    Locked

  3. Series A

    Jan 1, 2019

    Amount

    $10M

    Investors

    Locked

  4. Angel

    May 1, 2018

    Amount

    $3M

    Investors

    Locked

Questions about Zion Pharma

Who invested in Zion Pharma?

Zion Pharma has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Zion Pharma raised?

Zion Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Zion Pharma last raise money?

Zion Pharma's most recent round on record is a Series B, in Jul 2021.

What does Zion Pharma do?

Based in Shanghai, China and established in 2018, Zion Pharma Limited is a bio-pharmaceutical company that focuses on the development of small molecule tumor drugs.

Where is Zion Pharma headquartered?

Zion Pharma is headquartered in Shanghai, China.

Which VCs invest in companies like Zion Pharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Zion Pharma's stage. Their profiles are linked below.

Raising like Zion Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.